Jeroen Dekervel

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Topics

Combination Therapy

Metastatic Colorectal Cancer

Prognostic Factors

Top Venues

OncoTargets and therapy

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Hepatology (Baltimore, Md.)

This page only lists publications with an associated author ORCID identifier.

Publications

Lien Smets, Annelies Debucquoy, Eva Oldenburger, Chantal Van Audenhove, Lynn Debrun, Jeroen Dekervel, Gabriele Bislenghi, André D'Hoore, Albert Wolthuis, Karin Haustermans
Development of a Patient Decision Aid for Rectal Cancer Patients with Clinical Complete Response after Neo-Adjuvant Treatment. Cancers 15 (3) (2023)
Sarah Cappuyns, Gino Philips, Vincent Vandecaveye, Bram Boeckx, Rogier Schepers, Thomas Van Brussel, Ingrid Arijs, Aurelie Mechels, Ayse Bassez, Francesca Lodi, Joris Jaekers, Halit Topal, Baki Topal, Orian Bricard, Junbin Qian, Eric Van Cutsem, Chris Verslype, Diether Lambrechts, Jeroen Dekervel
PD-1 - CD45RA + effector-memory CD8 T cells and CXCL10 + macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma. Nature communications 14 (1) (2023)
Eric Van Cutsem, Gilles Manceau, Rona Yaeger, Takayuki Yoshino, Axel Grothey, Evaristo Maiello, Elena Elez, Jeroen Dekervel, Paul J Ross, Ana Ruiz-Casado, Janet Graham, Takeshi Kato, Jose Carlos Ruffinelli, Thierry André, Edith Carrière Roussel, Isabelle Klauck, Mélanie Groc, Jean-Claude Vedovato, Josep Tabernero
ANCHOR CRC: Results From a Single-Arm, Phase II Study of Encorafenib Plus Binimetinib and Cetuximab in Previously Untreated BRAF V600E -Mutant Metastatic Colorectal Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Lien Smets, Annelies Debucquoy, Eva Oldenburger, Chantal Van Audenhove, Lynn Debrun, Jeroen Dekervel, Gabriele Bislenghi, André D'Hoore, Albert Wolthuis, Karin Haustermans
Development of a Patient Decision Aid for Rectal Cancer Patients with Clinical Complete Response after Neo-Adjuvant Treatment. Cancers 15 (3) (2023)
Cedric Brackenier, Lisa Kinget, Sarah Cappuyns, Chris Verslype, Benoit Beuselinck, Jeroen Dekervel
Unraveling the Synergy between Atezolizumab and Bevacizumab for the Treatment of Hepatocellular Carcinoma. Cancers 15 (2) (2023)
Cedric Brackenier, Lisa Kinget, Sarah Cappuyns, Chris Verslype, Benoit Beuselinck, Jeroen Dekervel
Unraveling the Synergy between Atezolizumab and Bevacizumab for the Treatment of Hepatocellular Carcinoma. Cancers 15 (2) (2023)
Elin Pauwels, Frederik Cleeren, Térence Tshibangu, Michel Koole, Kim Serdons, Lennert Boeckxstaens, Jeroen Dekervel, Timon Vandamme, Willem Lybaert, Bliede Van den Broeck, Annouschka Laenen, Paul M Clement, Karen Geboes, Eric Van Cutsem, Sigrid Stroobants, Chris Verslype, Guy Bormans, Christophe M Deroose
18 F-AlF-NOTA-octreotide outperforms 68 Ga-DOTA-TATE/-NOC PET in neuroendocrine tumor patients: results from a prospective, multicenter study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine (2022)
Carolien Beyls, Karin Haustermans, Christophe M Deroose, Steven Pans, Dirk Vanbeckevoort, Chris Verslype, Jeroen Dekervel
Could Autoimmune Disease Contribute to the Abscopal Effect in Metastatic Hepatocellular Carcinoma? Hepatology (Baltimore, Md.) 72 (3) (2021)
Ashenafi Bulle, Jeroen Dekervel, Lise Deschuttere, David Nittner, Eric Van Cutsem, Chris Verslype, Jos van Pelt
Anti-Cancer Activity of Acriflavine as Metabolic Inhibitor of OXPHOS in Pancreas Cancer Xenografts. OncoTargets and therapy 13 (2020)